Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Tatva Chintan Pharma Chem has informed that it enclosed a copy of the Monitoring agency report of the Company for the quarter ended 30 September 2021, issued by ICICI Bank, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company.
The above information is a part of company’s filings submitted to BSE.